Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Seattle Genetics adds to senior management team

This article was originally published in Scrip

Executive Summary

Seattle Genetics (US) has appointed Dr Elaine Waller senior vice-president of regulatory affairs and Christopher Pawlowicz senior vice-president of human resources. Dr Waller was previously with Sonus Pharmaceuticals, where she served as senior vice-president of regulatory affairs/quality assurance and clinical research, until its merger with OncoGenex Pharmaceuticals in August. Mr Pawlowicz was previously senior vice-president of human resources and administration at MedPointe Pharmaceuticals. Seattle Genetics has also promoted Dr Jonathan Drachman from senior medical director to vice-president of early clinical development.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts